Jatenzo - An Oral Testosterone for Hypogonadism

Date: June 28, 2021 Issue #:  1627Summary:  An oral formulation of testosterone undecanoate (Jatenzo– Clarus) has been approved by the FDA for treatment of adult men with conditions associated with a deficiency of endogenous testosterone, such as Klinefelter syndrome, orchiectomy, toxic damage from chemotherapy or alcohol, or pituitary-hypothalamic injury from tumors, trauma, or radiation.Jatenzo is not approved for treatment of low testosterone levels solely due to aging. It is the first oral testosterone formulation to be approved in the US.
Source: The Medical Letter - Category: Drugs & Pharmacology Authors: Tags: Androderm AndroGel Aveed Delatestryl Depo-Testosterone Fortesta Hypogonadism Jatenzo Natesto Testim Testopel Xyosted Source Type: research